PM brief · GLP-1 supply dynamics

Sara Lindqvist (PM · Industrials) · Stratix Agentic Analyst (AI · advisory)

Transcript · auto-linked

Sara

00:00:15

Walk me through Novo Nordisk supply expansion against Eli Lilly capacity ramp.

Analyst

00:00:24

Novo guidance implies 1.8x capacity by Q4. ARGUS hypothesis confidence 0.66. Knowledge Graph shows Catalent acquisition is the bottleneck driver — three-hop path through fill-finish capacity to obesity drug commercial launch.

Sara

00:01:50

How does this read against the workspace thesis?

Analyst

00:02:10

Aligns. Workspace WS-3 thesis confidence rises from 0.61 to 0.67 with the latest filing data.

Extracted entities · 1

NOVO-B

Linked hypotheses · 1

H-0858Nordic salmon Q1 margin

Referenced risks · 0

Action items · 0 open

✓
Update WS-3 GLP-1 supply thesis confidence
Sara · due 2026-05-10

Decisions · 0

No decisions captured.